Specifically, this activation effect is mainly reflected in two aspects: it further activates the downstream mTOR molecules through the Akt-mTOR axis, directly promoting the synthesis of muscle proteins and inhibits the binding of the myostatin promoter, thereby reducing the expression of myostatin and ultimately alleviating muscle atrophy
Compounded medications are not FDA approved and carry risks related to inconsistent potency, sterility, and formulation quality
Nausea typically peaks around weeks 6 to 8 as the dose escalates through 4 mg and 8 mg
Each visit should cover your weight trajectory, side effect management, metabolic markers (periodic lab work), medication adherence, and any new symptoms or concerns
Theyre very expensive
Gallbladder disease risk may be increased with GLP-1 receptor agonists, particularly with substantial weight loss